Skip to main content

Scholarship opportunity for legally blind students

This is another item I'm passing along for those that might be interested. It's never too early to get started on these things. I am a former national scholarship winner. My advice is to keep trying if you haven't been successful in the past. The year I won my national scholarship was the second year I applied. Unfortunately, I didn't know I had HPS then and was horribly ill at the conference. I'm sure no one knew how ill I was as I was trying to cover it up and compete. I nearly passed out on several occassions and was so tired because I was GI bleeding and getting very anemic.

Most state affiliates also have scholarship programs, and usually the application form is the same. Apply at both the state and the national level. Good luck!!!!


For Blind High School Seniors through Grad School Students






$12,000 Scholarship






The Kenneth Jernigan $12,000 Scholarship


and


1 Scholarship for $10,000


2 Scholarships for $7,000 each


4 Scholarships for $5,000 each


22 Scholarships for $3,000 each


PLUS other gifts to scholarship winners!










ARE YOU A LEGALLY BLIND STUDENT?


Go to:


www.nfb.org/scholarships










NATIONAL FEDERATION OF THE BLIND


2011 SCHOLARSHIP PROGRAM






Contest begins: November 2010


To apply, read the rules and the Submission Checklist, complete the official 2011 Scholarship Application Form (online or print), send all required documents by the March 31 deadline, and complete one telephone interview with our representative by April 15, 2011.














Deadline: March 31, 2011


All documentation must be received or postmarked by the deadline.






Questions to: NFB Scholarship Program. E-mail: Scholarships@nfb.org


Office: (410) 659 -9314, extension 2415 (8 a.m. - 5 p.m. ETZ)
























Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria